Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Gelatin sponge are generally small, sterile, and surgical sponges that are used in surgical procedures as a haemostatic device. Each gelatin sponge is capable of absorbing and holding blood according to its mesh size. Gelatin sponges are prepared from specially treated and purified gelatin solution. Gelatin sponge marketed products are sterile and are intended for single use, as reuse can result in transmission of HIV and hepatitis, which can endanger patients and health care providers. Gelatin sponges are mainly stored at 25 but can extend storage temperature by 15 to 30 .
The global gelatin sponge market is estimated to be valued at US$ 195.9 million in 2020 and is expected to exhibit a CAGR of 4.20 % during the forecast period (2020-2027).
Figure 1. Global Gelatin Sponge Market Value (US$ Mn), 2016-2027
The increasing incidence of plastic surgeries is expected to drive growth of the gelatin sponge market over the forecast period. For instance, according to the report published by the American Society of Plastic Surgeon 2019, in 2019, around 1.8 million of cosmetic surgical procedures were carried out in the U.S. and also stated that 16.3 million of minimally invasive cosmetic procedures were carried out in U.S. in the same year.
Moreover, increasing prevalence of cancer such as oral cancer is expected to drive demand for gelatin sponge over the forecast period. For instance, according to the World Health Organization 2019, oral cancer is one of the top three most common cancers in Asia Pacific.
Gelatin Sponge Market Report Coverage
||Market Size in 2020:
||US$ 195.9 Mn
|Historical Data for:
||2016 to 2019
||2020 to 2027
|Forecast Period 2020 to 2027 CAGR:
||2027 Value Projection:
||US$ 261.2 Mn
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC, Israel, and Rest of the Middle East
- Africa: South Africa, North Africa, and Central Africa
- By Application: Plastic Surgery, Neurosurgery, General Surgery, Dental Surgery, ENT Surgery, Anorectal Surgery, Abdominal Surgery, Others.
- By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers.
Baxter International Inc, Gelita AG, Johnson & Johnson, Pfizer Inc, B. Braun, Ferrosan Medical Devices A/S, Eucare Pharmaceuticals Private Limited, CURA Healthcare Pvt. Ltd, Angel Life Science, Genco Tibbi Cihazlar Limited, Aegis Lifescience, and Saintroy Lifescience
- Increasing prevalence of surgical procedures such as plastic surgery and cancer surgery
- Robust product pipeline of new gelatin sponge devices globally
|Restraints & Challenges:
- Toxic shock syndrome is observed due to gelatin sponge use in nasal surgeries
- Leads to formation of abscess (skin damage)
Global Gelatin Sponge Market – Impact of Coronavirus (COVID-19)
Following the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries, across the globe and the World Health Organization has declared it as a public health emergency. According to the World Health Organization’s report, the manifestation of the coronavirus (COVID-19) has resulted in over 43.4 million infected individuals, worldwide, as of October 27, 2020.
The coronavirus (COVID-19) pandemic and resulting lockdown in various countries across the globe have impacted the financial status of businesses in all sectors. The private healthcare sector is one of the sectors, which has been majorly impacted by the COVID-19 pandemic. The pandemic has negatively impacted the global gelatin sponge market by affecting directly on development, production, and supply of medical devices and has also affected growth of the pharmaceutical businesses of various companies globally due to lockdowns implemented by governments of several countries. The nationwide lockdowns have led to closure of industrial establishments, except manufacturing of essential commodities and disruption in supply chain of the pharmaceuticals and kits for diagnostic and therapeutic use.
Figure 2. Global Gelatin Sponge Market Share (%), by Region, 2020
Among regions, North America is expected to witness significant growth in the global gelatin sponge market, owing to increasing number of surgical procedures in the region. For instance, according to the Center of Disease Control and Prevention 2017, around 48.9 million of surgeries were performed with an estimation of 25.7 million surgeries were performed in hospitals and 22.5 million were performed in ambulatory surgical centers in the U.S.
Major players operating in the global gelatin sponge market include Baxter International Inc, Gelita AG, Johnson & Johnson, Pfizer Inc, B. Braun, Ferrosan Medical Devices A/S, Eucare Pharmaceuticals Private Limited, CURA Healthcare Pvt. Ltd, Angel Life Science, Genco Tibbi Cihazlar Limited, Aegis Lifescience, and Saintroy Lifescience.